TARO-DOXORUBICIN LIPOSOMAL

Google image searchProduct monograph

Active ingredient

doxorubicin hydrochloride, 2 MG/ML

DIN: 02493020

Dosage form(s): SUSPENSION

Route(s) of administration: INTRAVENOUS

Schedule: Prescription

Company: TARO PHARMACEUTICALS INC

Date: 19-MAY-2020

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01D — CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES (ATC, ATC/DDD)
• L01DB — Anthracyclines and related substances (ATC, ATC/DDD)
• L01DB01 — DOXORUBICIN (ATC/DDD)

Reference brand drug: Adriamycin, Caelyx

External Links for Taro-Doxorubicin Liposomal

Search on Google

• Taro-Doxorubicin Liposomal side effects
• Taro-Doxorubicin Liposomal dosage
• doxorubicin hydrochloride side effects
• doxorubicin hydrochloride dosage

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-doxorubicin liposomal photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.